Rani Therapeutics Holdings, Inc.
RANI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 100% | – | – | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,914.7% | – | – | -1,917% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,920% | – | – | -306.6% |
| EPS Diluted | -1.05 | -1.33 | -1.28 | -0.42 |
| % Growth | 21.1% | -3.9% | -204.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |